Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis

Frontiers in Cellular and Infection Microbiology - Switzerland
doi 10.3389/fcimb.2018.00332
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Regulatory Potential of Post-Translational Modifications in Bacteria

Frontiers Research Topics
2015English

Translational Therapeutics of Dipyridamole

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2008English

Myeloid-Derived Suppressor Cells and Myeloid Regulatory Cells in Cancer and Autoimmune Disorders

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

Editorial: Targeting Myeloid Cells to Fight Cancer

Frontiers in Immunology
AllergyImmunology
2019English

Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells With MEK/ERK Signaling Pathway Inhibitors

PLoS ONE
Multidisciplinary
2015English

Targeting DNA Replication and Repair for the Development of Novel Therapeutics Against Tuberculosis

Frontiers in Molecular Biosciences
BiochemistryGeneticsMolecular Biology
2017English

Targeting Microenvironment in Cancer Therapeutics

Oncotarget
Oncology
2016English

Extending the Translational Potential of Targeting NO/cGMP-regulated Pathways in the CVS

British Journal of Pharmacology
Pharmacology
2015English

Translational Therapeutics in Genetically Engineered Mouse Models of Cancer

Cold Spring Harbor Protocols
BiochemistryGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy